Skip to site menu Skip to page content
EMBO CAPS by Suheung
Go back
Send enquiry

Subscribed

You have successfully submitted your enquiry. Someone from our company will respond ASAP

EMBOCAPS® LPR for Dry Powder Inhalation

EMBOCAPS® LPR for Dry Powder Inhalation-feature-image

Asthma remains one of the most widespread respiratory conditions worldwide, affecting nearly 300 million people and contributing to approximately 1,000 deaths every day. As the prevalence of respiratory diseases continues to rise, the need for effective and reliable inhalation therapies becomes increasingly critical.

In dry powder inhaler (DPI) systems, capsule performance plays an essential role in ensuring efficient drug delivery and consistent patient outcomes. Factors such as powder retention, capsule puncture behaviour, and overall capsule integrity can significantly influence inhalation performance.

EMBOCAPS® LPR (Low Powder Retention) capsules are specifically designed to support dry powder inhalation technologies. Engineered to minimise powder retention and enhance delivery efficiency, EMBOCAPS® LPR helps manufacturers achieve reliable dosing and optimised inhalation performance.

With decades of expertise in capsule manufacturing and a strong commitment to quality and consistency, EMBOCAPS® continues to support pharmaceutical partners worldwide in developing advanced inhalation therapies.

Discover how EMBOCAPS® LPR capsules can support your next inhalation product.

Related Content